Geode Capital Management’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $717K | Sell |
618,167
-737,502
| -54% | -$856K | ﹤0.01% | 3436 |
|
|
2025
Q1 | $2.16M | Buy |
1,355,669
+42,705
| +3% | +$67.9K | ﹤0.01% | 3006 |
|
|
2024
Q4 | $3.98M | Buy |
1,312,964
+20,864
| +2% | +$63.2K | ﹤0.01% | 2852 |
|
|
2024
Q3 | $4.76M | Sell |
1,292,100
-42,359
| -3% | -$156K | ﹤0.01% | 2784 |
|
|
2024
Q2 | $5.46M | Buy |
1,334,459
+32,222
| +2% | +$132K | ﹤0.01% | 2676 |
|
|
2024
Q1 | $20.5M | Buy |
1,302,237
+48,500
| +4% | +$764K | ﹤0.01% | 1908 |
|
|
2023
Q4 | $19M | Buy |
1,253,737
+66,900
| +6% | +$1.01M | ﹤0.01% | 1953 |
|
|
2023
Q3 | $23.8M | Buy |
1,186,837
+119,236
| +11% | +$2.39M | ﹤0.01% | 1712 |
|
|
2023
Q2 | $30.1M | Buy |
1,067,601
+171,676
| +19% | +$4.84M | ﹤0.01% | 1581 |
|
|
2023
Q1 | $15.4M | Buy |
895,925
+38,708
| +5% | +$666K | ﹤0.01% | 1972 |
|
|
2022
Q4 | $17.3M | Buy |
857,217
+21,007
| +3% | +$423K | ﹤0.01% | 1867 |
|
|
2022
Q3 | $18.1M | Buy |
836,210
+54,766
| +7% | +$1.19M | ﹤0.01% | 1809 |
|
|
2022
Q2 | $22M | Buy |
781,444
+115,380
| +17% | +$3.24M | ﹤0.01% | 1700 |
|
|
2022
Q1 | $30.7M | Buy |
666,064
+4,853
| +0.7% | +$224K | ﹤0.01% | 1597 |
|
|
2021
Q4 | $55.6M | Buy |
661,211
+18,557
| +3% | +$1.56M | 0.01% | 1228 |
|
|
2021
Q3 | $42.8M | Buy |
642,654
+198,889
| +45% | +$13.3M | 0.01% | 1406 |
|
|
2021
Q2 | $23.6M | Buy |
443,765
+76,925
| +21% | +$4.09M | ﹤0.01% | 1855 |
|
|
2021
Q1 | $15.9M | Buy |
366,840
+35,051
| +11% | +$1.52M | ﹤0.01% | 2023 |
|
|
2020
Q4 | $17.2M | Buy |
331,789
+150,342
| +83% | +$7.81M | ﹤0.01% | 1812 |
|
|
2020
Q3 | $5.93M | Buy |
181,447
+19,112
| +12% | +$625K | ﹤0.01% | 2291 |
|
|
2020
Q2 | $7.8M | Buy |
+162,335
| New | +$7.8M | ﹤0.01% | 2080 |
|